These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 5038959)

  • 1. The Jennerian approach to gram-negative bacillary bacteremia?
    Sanford JP
    N Engl J Med; 1972 Aug; 287(6):304-5. PubMed ID: 5038959
    [No Abstract]   [Full Text] [Related]  

  • 2. Type-specific and cross-reactive antibodies in gram-negative bacteremia.
    McCabe WR; Kreger BE; Johns M
    N Engl J Med; 1972 Aug; 287(6):261-7. PubMed ID: 5038951
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of sepsis/septic shock in surgery of the digestive system].
    Higuero Moreno F; de la Cruz Vigo JL; de la Cruz Vigo F; de la Cruz Caro F
    Rev Esp Enferm Apar Dig; 1981 May; 59(5):553-68. PubMed ID: 7291668
    [No Abstract]   [Full Text] [Related]  

  • 4. Potential use of shared antigens for immunization against gram-negative bacillary infections.
    McCabe WR; DeMaria A; Johns M
    Prog Clin Biol Res; 1980; 47():107-17. PubMed ID: 6163155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic strategies in cases of septicemia caused by gram-negative bacteria].
    Łukasiewicz J; Ługowski C
    Postepy Hig Med Dosw; 2003; 57(3):251-62. PubMed ID: 14524245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Calandra T; Baumgartner JD; Glauser MP
    Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement activation in septic shock due to gram-negative and gram-positive bacteria.
    León C; Rodrigo MJ; Tomasa A; Gallart MT; Latorre FJ; Rius J; Brugués J
    Crit Care Med; 1982 May; 10(5):308-10. PubMed ID: 6918253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological intervention in endotoxin shock.
    Ziegler EJ
    Prog Clin Biol Res; 1988; 272():319-25. PubMed ID: 3293079
    [No Abstract]   [Full Text] [Related]  

  • 9. [Protective properties of antibodies raised against conjugates of endotoxin core oligosaccharides with proteins].
    Jachymek W
    Postepy Hig Med Dosw; 1995; 49(1):171-8. PubMed ID: 8657614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum complement levels in bacteremia due to gram-negative organisms.
    McCabe WR
    N Engl J Med; 1973 Jan; 288(1):21-3. PubMed ID: 4629164
    [No Abstract]   [Full Text] [Related]  

  • 11. [Gram-negative bacteria septicemia].
    Klastersky J
    Nouv Presse Med; 1972 Jan; 1(3):183-7. PubMed ID: 5061529
    [No Abstract]   [Full Text] [Related]  

  • 12. Gram-negative bacteremia.
    McCabe WR
    Adv Intern Med; 1974; 19():135-58. PubMed ID: 4592709
    [No Abstract]   [Full Text] [Related]  

  • 13. [Infection and septic shock. Aggression and defense].
    Opferkuch W
    Verh Dtsch Ges Inn Med; 1987; 93():330-6. PubMed ID: 3442110
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group.
    Ziegler EJ; Fisher CJ; Sprung CL; Straube RC; Sadoff JC; Foulke GE; Wortel CH; Fink MP; Dellinger RP; Teng NN
    N Engl J Med; 1991 Feb; 324(7):429-36. PubMed ID: 1988827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy in gram-negative bacterial infections.
    Lugowski C
    Acta Biochim Pol; 1995; 42(1):19-24. PubMed ID: 7653155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of monoclonal antibodies in the management of gram-negative sepsis. Experience with the E5 antibody.
    Gorelick KJ; Chmel H
    Infect Dis Clin North Am; 1991 Dec; 5(4):899-913. PubMed ID: 1783775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nosocomial gram-negative bacillary infections in compromised hosts: considerations on prevention and therapy.
    Klastersky J
    Br J Clin Pract Suppl; 1988 Feb; 57():3-10. PubMed ID: 3140872
    [No Abstract]   [Full Text] [Related]  

  • 18. Nosocomial infections due to gram-negative bacilli in compromised hosts: considerations for prevention and therapy.
    Klastersky J
    Rev Infect Dis; 1985; 7 Suppl 4():S552-8. PubMed ID: 3909312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gentamicin resistance among gram-negative bacillary blood isolates in a hospital with long-term use of gentamicin.
    Mylotte JM
    Arch Intern Med; 1987 Sep; 147(9):1642-4. PubMed ID: 3307673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition and control of outbreaks of nosocomial infections in the intensive care setting.
    Tafuro P; Ristuccia P
    Heart Lung; 1984 Sep; 13(5):486-95. PubMed ID: 6565683
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.